Basing RNA-seq explored the regulatory mechanism of the carbohydrate metabolism pathways during chicken male germ cell differentiation
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
Authors: Lian, Chao; Zuo, Qisheng; Li, Dong; Zhang, Lei; Ahmed, Mahmoud F.; Xiao, Tianrong; Tang, Beibei; Wang, Yingjie; Jin, Kai; Zhang, Yani; Li, Bichun
Abstract
Our study aimed to explore the regulatory mechanism of the carbohydrate metabolism signaling pathways and related genes during the differentiation of chicken embryonic stem cells to male germ cells, providing the basis for improving the efficiency of the in vitro induction system. Cell sorting was used to obtain highly purified embryonic stem cells (ESCs), primitive germ cells (PGCs), and spermatogonial stem cells (SSCs). The total RNA was then extracted from each cell type. The transcriptions of ESCs, PGCs, and SSCs were sequenced by DNA microarray and mRNA sequencing (RNA-seq). The results were analyzed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. The key pathways and genes of carbohydrate metabolism were screened during the differentiation process of chicken male germ cell. We concluded that 419 differentially expressed genes enriched to 26 carbohydrate metabolism pathways during the differentiation process of ESCs to SSCs, all of the chondroitin sulfate (CS) signaling pathway was significant. We screened the key genes CHSY3, B3GAT1, CHPF, and B4GALT7 which was significantly expressed in CS pathway. Quantitative RT-PCR showed that the expression trend of these genes is consistent with DNA Microarray and RNA-seq results. Our study supports the opinion that CS pathway is significantly different during the differentiation of chicken male germ cell (P < 0.05) and that CHSY3, B3GAT1, CHPF, and B4GALT7 are key genes.
Defining the genetic control of human blood plasma N-glycome using genome-wide association study
HUMAN MOLECULAR GENETICS
Authors: Sharapov, Sodbo Zh.; Tsepilov, Yakov A.; Klaric, Lucija; Mangino, Massimo; Thareja, Gaurav; Shadrina, Alexandra S.; Simurina, Mirna; Dagostino, Concetta; Dmitrieva, Julia; Vilaj, Marija; Vuckovic, Frano; Pavic, Tamara; Stambuk, Jerko; Trbojevic-Akmacic, Irena; Kristic, Jasminka; Simunovic, Jelena; Momcilovic, Ana; Campbell, Harry; Doherty, Margaret; Dunlop, Malcolm G.; Farrington, Susan M.; Pucic-Bakovic, Maja; Gieger, Christian; Allegri, Massimo; Louis, Edouard; Georges, Michel; Suhre, Karsten; Spector, Tim; Williams, Frances M. K.; Lauc, Gordan; Aulchenko, Yurii S.
Abstract
Glycosylation is a common post-translational modification of proteins. Glycosylation is associated with a number of human diseases. Defining genetic factors altering glycosylation may provide a basis for novel approaches to diagnostic and pharmaceutical applications. Here we report a genome-wide association study of the human blood plasma N-glycome composition in up to 3811 people measured by Ultra Performance Liquid Chromatography (UPLC) technology. Starting with the 36 original traits measured by UPLC, we computed an additional 77 derived traits leading to a total of 113 glycan traits. We studied associations between these traits and genetic polymorphisms located on human autosomes. We discovered and replicated 12 loci. This allowed us to demonstrate an overlap in genetic control between total plasma protein and IgG glycosylation. The majority of revealed loci contained genes that encode enzymes directly involved in glycosylation (FUT3/FUT6, FUT8, B3GAT1, ST6GAL1, B4GALT1, ST3GAL4, MGAT3 and MGAT5) and a known regulator of plasma protein fucosylation (HNF1A). However, we also found loci that could possibly reflect other more complex aspects of glycosylation process. Functional genomic annotation suggested the role of several genes including DERL3, CHCHD10, TMEM121, IGH and IKZF1. The hypotheses we generated may serve as a starting point for further functional studies in this research area.